Interventional, Monocentric, Double-blind Randomized Category 2b Study Evaluating the Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post -Inflammatory Hyperpigmentation (Pih)) on the Face

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 16, 2024

Primary Completion Date

December 12, 2024

Study Completion Date

December 12, 2024

Conditions
LentigoSolar LentigoPost Inflammatory Hyperpigmentation
Interventions
DEVICE

CRYONOVE (EC14_4osc)

The prototype is a variant version from that of a CE marked MD already commercialized (Cryobeauty mains, Cryobeauty Pharma SAS, France) which produces a cryogenic spray sequence (EC14). The prototype is intended to treat pigmented spots of the face (PIH spots and senile and solar lentigos).

DEVICE

CRYONOVE (EC05osc)

The prototype is a variant version from that of a CE marked MD already commercialized (Cryobeauty mains, Cryobeauty Pharma SAS, France) which produces a cryogenic spray sequence (EC05). The prototype is intended to treat pigmented spots of the face (PIH spots and senile and solar lentigos).

Trial Locations (1)

Unknown

SMU - Photobiology Laboratory, Sefako Makgatho Health Sciences University, Pretoria

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Dermatech

INDUSTRY

lead

Cryonove Pharma

INDUSTRY

NCT06361251 - Interventional, Monocentric, Double-blind Randomized Category 2b Study Evaluating the Evaluation of the Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots (Solar and Senile Lentigines, Post -Inflammatory Hyperpigmentation (Pih)) on the Face | Biotech Hunter | Biotech Hunter